2018•Investigative Ophthalmology & Visual ScienceOpen access

Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results

Caitlen Taylor, Heather Frazier, Priscila Rex, William B. Marcus, Davis Starnes, Harveen Walia, Harinderjit Singh, Robert Lalane, Dennis M. Marcus

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ranibizumab, Aflibercept, Diabetic macular edema, Medicine, Bevacizumab, Ophthalmology, Diabetic retinopathy, Surgery

Back to paper search Browse research topics Original source

Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results — Research Paper | ScholarLens